New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XLVvsIHEETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-1.91%
Full XLV fund page
VS
ETF 2
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-1.91%
Full IHE fund page

State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.38% for IHE. XLV is down -2.96% year-to-date (YTD) with +$900M in YTD flows. IHE performs better with 2.22% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of XLV and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV vs IHE performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.03.0%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

-800 M-600 M-400 M-200 M0 M200 M400 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
IHE
-3.74%-3.87%
-2.07%+2.93%
-2.96%+2.22%
+5.69%+27.13%
+25.97%+60.07%
+41.91%+57.13%
Flows
XLV
IHE
-$710M+$9M
-$28M+$146M
+$900M+$129M
-$38M+$248M
-$4.95B+$359M
+$6.87B+$393M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
IHE
+14.03%+16.35%
+17.46%+20.48%
+13.62%+15.97%
+14.49%+15.82%
Max drawdown
XLV
IHE
-6.25%-5.64%
-12.43%-14.18%
-17.05%-16.04%
-17.05%-16.12%
Max drawdown duration
XLV
IHE
11d11d
211d150d
444d210d
444d669d
Trading data

Create an account to view trading data

Join for free
XLV
IHE
Last sale
3/12/2026 at 1:30 PM
$150.16
$86.66
Previous close
03/12/2026
$152.85
$88.40
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
XLV
IHE
Last price
$150.16
$86.66
1D performance
-1.76%
-1.97%
AuM$39.37 B$996.54 M
E/R0.08%0.38%
Characteristics
XLV
IHE
Management strategyPassivePassive
ProviderSPDRiShares
BenchmarkS&P Health Care Select Sector IndexDow Jones U.S. Select Pharmaceuticals Index
N° of holdings5746
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998May 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

XLV
USA
96.98%
Other
3.02%
IHE
USA
90.92%
Other
9.08%

Sectors

XLV
Health Care
98.26%
Other
1.74%
IHE
Health Care
96.19%
Other
3.81%
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

70.12%
IHE

Total weight of top 15 holdings out of 15

84.8%

Top 15 holdings

Data as of January 31, 2026
XLV
LILLY
14.69%
JOHNSON&JOHNSON
9.77%
ABBVIE
7.03%
MERCK & CO INC
4.88%
UNITEDHEALTH GRP
4.64%
THERMO FISHER SCIENTIFIC
3.88%
ABBOTT LABS
3.39%
AMGEN-T
3.28%
INTUITIVE SURGICAL
3.19%
GILEAD SCIENCES
3.14%
PFIZER
2.68%
BOSTON SCIENTIFIC
2.47%
DANAHER
2.45%
MEDTRONIC PLC
2.36%
STRYKER
2.27%
IHE
JOHNSON&JOHNSON
23.72%
LILLY
22.21%
MERCK & CO INC
4.78%
BRISTOL-MYERS SQUIBB
4.57%
ZOETIS INC
4.44%
PFIZER
4.36%
ROYALTY PHARMA
4.08%
VIATRIS INC
4.00%
ELANCO ANIMAL HEALTH INC
3.20%
JAZZ PHARMACEUTICALS
2.65%
AXSOME THERA CMN STK
2.09%
CRINETICS PHARMACEUTICALS
1.41%
US45579U1097
1.15%
CORCEPT THERAPEUTICS
1.11%
LIGAND PHARMACEUTICALS
1.02%
Frequently asked questions about XLV and IHE

How have the XLV and IHE ETFs performed in 2026?

As of March 12, 2026, XLV is down -2.96% year-to-date (YTD), while IHE has returned 2.22%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: XLV or IHE?

Year-to-date, the XLV ETF saw +$900M in flows, compared to +$129M for IHE.

Which ETF is more volatile: XLV or IHE?

Over the past year, XLV had a volatility of 17.46%, while IHE experienced 20.48%.

Which ETF is bigger: XLV or IHE?

As of March 12, 2026, XLV holds $39.37 B in assets under management (AUM), while IHE manages $996.54 M.

What sectors do the XLV and IHE ETFs invest in?

XLV leans toward sectors like Health Care. Meanwhile, IHE focuses on Health Care.

What are the top holdings of the XLV ETF and IHE ETF?

XLV top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. IHE holds in its top three: JOHNSON&JOHNSON, LILLY and MERCK & CO INC.

Which ETF is more diversified: XLV or IHE?

XLV holds 60 securities with 70.12% of its assets in the top 15. IHE has 56 securities and a top 15 weight of 84.8%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up